1. Home
  2. BIOR

BIOR

Biora Therapeutics Inc.

Logo Biora Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Founded: 2010 Country:
N/A
Employees: N/A City: SAN DIEGO
Market Cap: 21.4M IPO Year: 2020
Target Price: $50.00 AVG Volume (30 days): 440.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.87 EPS Growth: N/A
52 Week Low/High: $0.66 - $6.70 Next Earning Date: 01-01-0001
Revenue: $4,000 Revenue Growth: -98.69%
Revenue Growth (this year): 44600% Revenue Growth (next year): 142.62%

Share on Social Networks: